Purpose: To compare fundus fluorescein angiography (FFA) and swept-source optical coherence tomography angiography (SS-OCTA) in the evaluation of macular perfusion in diabetic patients.
D
iabetic retinopathy (DR) is one of the major causes of legal blindness worldwide 1 and the leading cause of vision loss in adults aged 20 years to 74 years. 2 Diabetic macular ischemia (DMI) is one of the commonest findings in diabetic patients: Sim et al 3 demonstrated the presence of some degree of DMI in approximately 40% of cases of patients with DR in a tertiary referral center. Diabetic macular ischemia is characterized by an enlargement of the foveal avascular zone (FAZ) and the presence of parafoveal areas of capillary nonperfusion ("drop-out"). Multiple studies have shown the correlation between impaired foveal perfusion in diabetic patients and their visual acuity. 4, 5 Furthermore, the progression of DMI has been linked to the potential deterioration of visual acuity 3 and thus, the importance of its recognition in the assessment of patients affected by DR. Recently, microscopic imaging studies on rodents have demonstrated the breakdown of the outer blood retinal barrier induced by ischemia. 6 The gold standard imaging technique for the assessment of macular perfusion is fundus fluorescein angiography (FFA). Fundus fluorescein angiography involves the intravenous injection of a fluorescent dye followed by serial fundus photographs. The most common and less serious side effects of FFA are nausea, vomiting, yellow pigmentation of skin, and urine. More serious adverse events include anaphylactoid reactions ranging from skin rash and itching to severe anaphylactic shock. An intrinsic limitation of the technique is related to the physical properties of the dye that can leak from pathologic blood vessels masking the underlying tissue fluorescence. 7 Spectral domain optical coherence tomography angiography (SD-OCTA) is a noninvasive technique that allows for the visualization of blood vessels by comparing the decorrelation signal between multiple sequential OCT B-scans taken at the same cross-section. 8 The resulting decorrelation map is a reconstruction of the network of blood vessels with erythrocytes flowing into them. Three different vascular layers can be visualized: the superficial capillary plexus (SP), deep capillary plexus (DP), and the choriocapillaris. Optical coherence tomography angiography does not involve the use of a dye, making it theoretically risk-free and independent from the physical properties of fluorescein. Extravasal leakage is often present in patients with DR due to the loss of pericytes and subsequent increased vascular permeability. Previous work by Bradley et al 9 demonstrated significant agreement between OCTA and FFA in the assessment of macular perfusion in subjects with DR.
Swept-source technology in ophthalmic imaging has been investigated extensively since the first report in 2006. 10 It uses longer-wavelength infrared light compared with traditional spectral domain OCT. This enables for faster scans (100,000 A-scans per second) and increased tissue penetration with easier imaging through media opacities and improved visualization of the choroid. Numerous reports have been published on the applications of OCTA in patients with DR. In 2015, Ishibazawa et al 11 have published a pilot study on the OCTA features of DR, imaging microaneurysms (MAs), venous beading, new vessels, and capillary drop-out. Takase et al 12 have demonstrated the presence of macular circulation impairment on OCTA even before the development of retinopathy. Agemy et al 13 have shown good correlation between OCTA images and the clinical features of DR.
A swept-source OCTA (SS-OCTA) device is available from the Japanese company TOPCON (Topcon Corporation, Tokyo, Japan): the DRI OCT Triton. Although most reports in the literature have used prototypes, 14, 15, 28 this is the first commercially available SS-OCTA device. The DRI OCT Triton uses the OCTARA (OCTA ratio analysis), 16 a specific algorithm that, according to the manufacturer, increases detection sensitivity of retinal microvasculature. [17] [18] [19] The aim of this study was to compare traditional FFA and SS-OCTA in the evaluation of macular perfusion in diabetic patients. To the best of our knowledge, this is the first report on this matter.
Methods
In this retrospective observational study, we aimed to systematically evaluate the quantitative and qualitative features of FFA and SS-OCTA images in the assessment of macular perfusion in diabetic patients.
The study location was the Medical Retina Service at Moorfields Eye Hospital, London. The period of study was from the January 1, 2016, until the May 28, 2016. Approval for data collection and analysis was obtained from the institutional review board of Moorfields Eye Hospital, and adhered to the tenets set forth in the Declaration of Helsinki.
Patient demographics and clinical data were obtained from electronic medical records. Previous retinopathy or maculopathy treatments were recorded. Inclusion criteria were: history of diabetes mellitus with or without evidence of retinopathy and/or maculopathy. Exclusion criteria were: significant media opacity that obscured the view of the fundus and concurrent ocular conditions interfering with normal retinal blood flow (e.g., age-related macular degeneration, retinal vein or arterial occlusion, radiation retinopathy, sickle-cell retinopathy, and idiopathic retinal telangiectasia).
Fundus fluorescein angiography and SS-OCTA images were acquired 1 week or within 1 month from each other.
Image Acquisition
Color fundus photographs and FFA obtained using the Topcon TRC50IX (Topcon Corporation) were used for DR severity grading.
Swept-source OCTA was performed using the Topcon DRI OCT Triton device (Topcon Corporation), using 2 different acquisition protocols: 3 · 3 mm and 4.5 · 4.5 mm, centered on the fovea (Figure 1) . A web-based ophthalmic data management platform, IMAGEnet6, was used for image processing.
Diabetic Retinopathy Grading
Grading of the retinopathy was based on the Early Treatment Diabetic Retinopathy Study (ETDRS) classification, endorsed in 2003 by the American Academy of Ophthalmology Guidelines Committee 20 and widely used in clinical trials.
Fundus Fluorescein Angiography Image Analysis
Standard fluorescein angiograms were obtained from our digital database and they were analyzed quantitatively and qualitatively by a single examiner. The examiner was masked in that he could not pair each image with the corresponding patient. Early-to-mid phase images were considered for the evaluation of macular perfusion and late frames were used to grade macular edema.
Quantitative analysis included measurement of maximum vertical and horizontal diameters (mm) as well as FAZ area (mm 2 ) for each fluorescein angiogram. The ImageJ suite, version 1.51a (available in the public domain at http://imagej.nih.gov) was used to analyze FFA images.
Qualitative analysis was performed at two different levels:
Macroscopic level. All images were classified based on standard reference photographs from the ETDRS DMI grading system with special regards to FAZ alterations. 21 According to this classification, a specific score is assigned as follows: absent (no alteration of the capillary outline), questionable (outline not smoothly round or oval, but visible irregularities, not definitely abnormal), mild (outline definitely destroyed for less than one half the original circumference), moderate (outline destroyed for one half or more of the original circumference, but some remnants remain), severe (capillary outline completely destroyed), and ungradable.
Macroscopic analysis also included stratifying each image into 1 of 4 quality categories (excellent, good, poor but gradable, and ungradable) based on the presence of image artifacts and their potential to limit detailed description of angiographic findings.
Microscopic level. Each FFA image was cropped to corresponding SS-OCTA 3 · 3 scan size using ImageJ to allow for direct comparison of microscopic changes. The resulting area was screened for specific angiographic features of DR. Microaneurysms, identified as early pinpoint hyperfluorescent lesions that faded in the later phases, vascular loops, and intraretinal microvascular abnormalities were located and counted. The presence of capillary drop-out (absence of retinal background fluorescence) was recorded.
Swept-Source Optical Coherence Tomography Angiography Image Analysis
Images obtained from the IMAGEnet6 database were analyzed from a quantitative and qualitative point of view by a single masked examiner. En face SS-OCTA images were generated for the SP only to allow for better comparison with corresponding FFA images. Manual segmentation was performed for each scan. A signal-to-noise ratio, expressed by the device as "TopQ index," below 60 was an exclusion criterion.
Quantitative analysis was performed using the ImageJ suite scaling each image with a built in plugin. The standard SS-OCTA image format imported from IMAGEnet6 was 320 · 320 pixels regardless of the scanning protocol used (3 · 3 or 4.5 · 4.5). ImageJ was instructed to scale the image proportionally from pixels to mm. Systematic measurements of both maximum vertical and horizontal diameters (mm), as well as FAZ area (mm 2 ), were included in the assessment using the "straight line" and "freehand" tools, respectively.
Qualitative analysis was performed as previously described for FFA at macroscopic level. Concerning microscopic analysis, this was performed after cropping each SS-OCTA 4.5 · 4.5 scan to corresponding 3 · 3 image size using the ImageJ software. Microaneurysms, identified as small round or oval hyperreflective lesions, vascular loops, and intraretinal microvascular abnormalities were located and counted. The presence of capillary drop-out (no-flow areas) was recorded. Figure 2 shows an example of microscopic diabetic retinal changes on corresponding FFA and SS-OCTA images.
Image artifacts were recorded and these included: white lines, vessel displacement, gap defects, and projection artifacts ( Figure 3 ).
Statistical Analyses
Descriptive statistics were used to summarize clinical characteristics. Normal distribution was assessed using the Kolmogorov-Smirnov test. Kruskal-Wallis test was performed to compare nonnormal distributed variables among three groups. The intraclass correlation coefficient (ICC) and its 95% confidence interval (CI) were used to assess the agreement between FFA and SS-OCTA in pairwise for continuous variables. Intraclass correlation coefficient (range: 0-1) was accepted as good agreement ICC 0.75 to 1, moderate agreement ICC 0.5 to 0.75, and poor agreement ICC , 0.5. 22 The agreement between imaging techniques was also assessed by Bland-Altman plots.
Weighted kappa test was used to assess the agreement of methods for ordinal variables in pairwise. To assess the interobserver agreement, weighted kappa values were used and 0.00 to 0.20 showed low agreement, 0.21 to 0.40 fair agreement, 0.41 to 0.60 moderate agreement, 0.61 to 0.80 good agreement, and 0.81 to 1.00 very good agreement. 23 A P value of ,0.05 was considered statistically significant. Statistical analyses were performed using the MedCalc13 software (Mariakerke, Belgium).
Results

Patient Demographics and Clinical Characteristics
Patient demographics and clinical characteristics are summarized in Table 1 . Forty-one eyes (21 patients) met the inclusion criteria. Mean patient age was 63.8 years (range, 37-81). The male:female ratio was 15:6. In 18 cases (43.7%), DR was diagnosed as nonproliferative, whereas proliferative diabetic retinopathy (PDR) was evident in 22 eyes (53.6%). Diabetic retinopathy was absent in just 1 case. Diabetic retinopathy did not require any form of treatment in 41.4% of our cohort (17 eyes). Twenty-four eyes (58.5%) underwent one or more sessions of panretinal photocoagulation because of the presence of proliferative disease and in three cases (7.3%), pars plana vitrectomy was performed to treat the complications of PDR. More than 70% of eyes were affected by any degree of diabetic macular edema. However, in 43.9% of eyes, no treatments were performed.
None of the patients enrolled in our study experienced severe side effects from fluorescein injection that might have compromised the examination. All FFA images collected covered early, mid, and late phases evenly.
Interval Between Fundus Fluorescein Angiography and Swept-Source Optical Coherence Tomography Angiography Imaging
The interval between 2 imaging techniques was less than 1 week in the majority of cases (30 eyes-73.1%). Anti-VEGF, anti-vascular endothelial growth factor; DME, diabetic macular edema; NPDR, nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; PRP, panretinal photocoagulation. In the remaining 11 cases, SS-OCTA was performed within 1 month from FFA.
Foveal Avascular Zone Quantitative Assessment
Foveal avascular zone quantitative analysis was possible for 35 eyes (85.3%) on FFA, 38 eyes (92.6%) on SS-OCTA 3 · 3, and 37 eyes (90.2%) on SS-OCTA 4.5 · 4. Measurements of vertical and horizontal maximum FAZ diameters are shown in Table 2 .
To evaluate maximum vertical diameter measurements of the FAZ, agreement of methods were analyzed in pairwise. Vertical measurement ICCs were significant between FFA and SS-OCTA 4.5 Horizontal FAZ measurements were evaluated with the same statistical method. Intraclass correlation Figure 4 shows an example of multimodal analysis with FAZ area evaluation.
The above results were also demonstrated using Bland-Altman plots (Figures 5-7) , assessing agreement for FAZ area measurement using three different techniques.
Early Treatment Diabetic Retinopathy Study Diabetic Macular Ischemia Grading
In most of the cases, DMI was classified as Moderate, regardless of the imaging technique used.
However, the cumulative number of patients with Moderate and Severe DMI was higher on SS-OCTA compared with FFA. Table 3 
Qualitative Assessment
Qualitative macroscopic assessment was possible in all cases. Figure 8 shows examples of FFA and SS-OCTA macroscopic stratification based on overall image quality. In most of the eyes, images were gradable both on FFA and SS-OCTA and they were considered of excellent or good quality in more than 70% of eyes on FFA and in more than 80% of cases on SS-OCTA. Images were deemed ungradable in 6 (14.6%), 3 (7.3%), and 4 (9.7%) cases on FFA and SS-OCTA 3 · 3 and 4.5 · 4.5, respectively.
Qualitative microscopic assessment was possible for all FFA images, whereas in three cases (SS-OCTA 3 · 3) and in four eyes (SS-OCTA 4.5 · 4.5), images were of poor quality, making it impossible to identify specific retinal diabetic changes. Microaneurysms and capillary drop-out were the commonest findings both on FFA and SS-OCTA (Table 4) .
Concerning analysis of MAs, almost the totality of FFA images (97.5%) demonstrated their presence, whereas MAs were noted in 56% and 65.8% of cases on SS-OCTA 3 · 3 and 4.5 · 4.5, respectively. Figure 9 is a very good example of superior sensitivity of FFA in identifying MAs compared with SS-OCTA technology and is representative of the whole cohort: except for few lesions where there is good correspondence in terms of number and location, several MAs could not be identified on SS-OCTA scans.
For all 41 eyes, SS-OCTA artifacts assessment was possible. White lines and vessel displacement were the commonest image artifacts both on 3 · 3 and 4.5 · 4.5 SS-OCTA protocols. Gap defects and projection artifacts were irrelevant. Overall, 4.5 · 4.5 images seemed less affected by artifacts: 39% of cases compared with 19.5% of eyes in the 3 · 3 group. Moreover, in 56% of 4.5 · 4.5 images, white lines were noted compared with 78% of eyes analyzed with the 3 · 3 protocol. Results are summarized in Table 5 .
Discussion
In this study, we compared the differences between FFA and SS-OCTA in the evaluation of macular perfusion of diabetic patients seen in a tertiary referral center over a 1-month interval.
Fundus fluorescein angiography is at present the gold standard imaging technique in the evaluation, management, and follow-up of patients affected by DR and maculopathy, but due to its potentially serious side effects, it may be precluded in patients with multiple comorbidities. Over the past few years, new technologies have been evaluated as an alternative to FFA and, to date, OCTA has shown the biggest potential in this field, being noninvasive, easy to acquire, and fast to perform. This is confirmed by the large number of peer-reviewed articles that have been published in the literature in recent years, showing big interest from the scientific community on this new technology. Spectral domain OCTA devices are so far the most widely studied, being the first ones that have become available in clinical practice. However, SS-OCTA is becoming increasingly popular thanks to its theoretical advantages (faster scans, deeper penetration through media opacities, and better imaging of the choroid) compared with spectral domain technology.
To the best of our knowledge, this is the first report systematically assessing the potential use of SS-OCTA as a noninvasive adjunct to traditional angiography in diabetic patients.
Our findings suggest that except for horizontal FAZ diameter measurement, where the agreement between FFA and SS-OCTA was moderate (ICCs 0.595, P , 0.001 and 0.742, P , 0.001 for FFA and SS-OCTA 3 · 3 and 4.5 · 4.5, respectively), the agreement was good in all other quantitative measurements (vertical FAZ diameter and FAZ area) regardless of the scan protocol used. However, ICCs were higher between SS-OCTA protocols in all quantitative measurements, confirming that this imaging technique has good reproducibility. The above conclusions, about FAZ area measurement, are confirmed using Bland-Altman plots. We may conclude that SS-OCTA is useful in supporting quantitative analysis of the FAZ but, at present, it cannot replace traditional FFA.
Regarding FAZ features in different stages of DR, we have noted the existence of a consistently larger FAZ in patients with PDR compared with eyes in the nonproliferative stage. The above conclusions are coherent with previous articles investigating the relationship between FAZ area and DR grading on FFA. 24 Similar results, about SD-OCTA, have already been reported by Bhanushali et al 25 and, according to our findings, they seem to be applicable for SS-OCTA as well. Previous studies have shown good agreement between FFA and SD-OCTA in the evaluation of DMI using the ETDRS protocol. 9, 26 Our results are not consistent with these findings because weighted kappa showed low to fair agreement between FFA and SS-OCTA. We may speculate that the longer wavelength used by swept-source technology influences the ability of the device to precisely identify the features of the SP. However, further studies are required to establish whether SS-OCTA is more sensitive in analyzing the DP compared with the SP.
Diabetic macular ischemia grading on SS-OCTA showed again good agreement between the 3 · 3 and 4.5 · 4.5 protocols (weighted kappa 0.654, 95% CI), confirming the fact that SS-OCTA has good reproducibility between different analysis protocols.
Concerning qualitative macroscopic analysis, despite the presence of SS-OCTA artifacts in a nonnegligible number of cases, most of the images seemed to be gradable and approximately half of them were considered of excellent quality for interpretation both on FFA and SS-OCTA. We may conclude that image quality degradation and artifacts intrinsic to both imaging techniques do not interfere significantly with interpretation, making them suitable for a high-volume clinic setting.
Microscopic assessment showed that MAs were one of the commonest findings both on FFA and SS-OCTA. Fundus fluorescein angiography identified more MAs than SS-OCTA and these results are consistent with other reports published in the literature on SD-OCTA 27 and SS-OCTA 28 : high-speed OCTA technology is known to limit identification of mainly low-flow lesions such as MAs.
Capillary drop-out was another common finding on both techniques and this is most likely due to a selection bias in our patient cohort. Most of the eyes enrolled in our study were affected by PDR; thus, the underlying advanced retinal disease resulted in an impaired blood supply often affecting the macular area.
Overall, traditional FFA is more sensitive in identifying early signs of DR; however, the clinician is unlikely to offer the patient an invasive test involving intravenous injection of a dye. Swept-source OCTA could be virtually performed in all diabetic patients as a first-line examination without fear of exposing them to potentially serious adverse events. However, the clinician should keep in mind the good potential of SS-OCTA in macular flow assessment (particularly FAZ analysis) versus the limits of this technology in identifying early signs of DR (MAs).
Image artifacts most frequently encountered on SS-OCTA were white lines and vessel displacement. In most cases, these were caused by patient eye movement during image capture and despite being the scans acquired by professional ophthalmic photographers, eye movement-related artifacts occurred in a significant number of eyes. Our experience suggests that although swept-source devices are based on fast imaging acquisition, motion artifacts are not completely absent; thus, a faster technology could potentially reduce their occurrence. Our study has one major strength: it is the first report that systematically compared two different imaging techniques, one of which introduced fairly recently, in the evaluation of macular perfusion and particularly the FAZ of diabetic patients.
In addition to this, we were the first ones to evaluate the potential of the 4.5 · 4.5 SS-OCTA analysis protocol. Anecdotally, we noted that speed acquisition was significantly higher compared with the 3 · 3 protocol and we assume this might partially justify our results in terms of image quality degradation: reduced scan time could have a positive impact in limiting motion-related artifacts on SS-OCTA 4.5 · 4.5. However, despite good agreement between SS-OCTA protocols demonstrated using ICCs, average FAZ measurements showed some variability. We infer that this difference might be related to theoretical different resolution between 4.5 · 4.5 and 3 · 3 protocols affecting quantitative evaluation of the FAZ. Further studies are required to support this hypothesis.
This study has several limitations, the first one being its retrospective nature. Another caveat is the small cohort size, limiting the statistical significance of our findings: large prospective studies are needed to confirm our encouraging results.
The selection bias represented by different baseline characteristics of the studied population, with special regards to macular edema and previous treatments, is another limitation of our study. A randomized design would exclude this bias.
Our arbitrary choice of taking into account only the SP on SS-OCTA further limits the significance of our findings and particularly our ability to detect early FAZ changes that may become visible in the DP before affecting the SP. However, recent evidence suggests that vessel density measurement of the DP may be influenced by the presence of coexisting macular edema due to the interference with image segmentation, 29, 30 whereas SP vessel density and FAZ measurement may be independent of the presence of cystoid edema. 31 Our preliminary results seem consistent with the latter report because we did not experience major interference between diabetic macular edema and FAZ analysis on SS-OCTA. However, further evidence is required to support these conclusions with statistical significance.
Technologic limitations of SS-OCTA, including increased variability with different axial lengths 32 and the impact of patient cooperation on image quality, introduce an intrinsic bias to our study that needs to be taken into account when drawing definitive conclusions.
In summary, SS-OCTA represents a useful, reliable, and easy-to-use imaging technique in the assessment of macular perfusion in diabetic patients with special regards to FAZ analysis. Both 3 · 3 and 4.5 · 4.5 analysis protocols seem to be reproducible; however, the agreement with traditional FFA remains limited especially in DMI grading. Fundus fluorescein angiography is more sensitive in identifying retinal MAs, but due to its potentially serious adverse events, it is not the ideal imaging technique for patients with early DR. Swept-source OCTA could theoretically find its place in this niche, especially for FAZ assessment, although the clinician should keep in mind its intrinsic limitations on identification of MAs. Based on our experience, overall image quality did not compromise SS-OCTA image interpretation.
Key words: diabetic macular ischemia, fluorescein angiography, foveal avascular zone, optical coherence, tomography angiography, swept-source.
